Solid Tumors

These resources provide a detailed overview of biomarker testing approaches and the importance of biomarker testing in select common solid tumors.

Optimizing Early Breast Cancer Care with Reflex Gene Expression Profiling Testing Workflows

This resource highlights the benefits of reflex GEP testing in reducing time to treatment for patients with early breast cancer (eBC), the involvement of the multidisciplinary team (MDT), and strategies for implementing reflex testing in clinical practice. 
Download the Optimizing Early Breast Cancer Care With Reflex Gene Expression Profiling Testing Workflows Brochure (PDF 5450 KB)

Standardizing Biomarker-Based Assessments for Risk of Recurrence in Early Breast Cancer

This resource explores the value of and considerations for implementing a standardized approach to evaluating risk of recurrence profiles in early breast cancer.
Download the Standardizing Biomarker-Based Assessments for Risk of Recurrence in Early Breast Cancer 1-Pager (PDF 0.26 MB)

Challenges to Personalized Treatment Initiation in eBC

This resource explores challenges to personalized treatment initiation throughout the diagnostic biomarker testing journey for patients with early breast cancer (eBC), covering topics from presentation to gene expression profiling or risk of recurrence testing, results reporting, and unmet needs in testing and care.
Download the Challenges to Personalized Treatment Initiation in eBC Flashcard (PDF 0.5 MB)

Addressing Disparities in Care - Biomarker Testing in Breast Cancer

This resource provides an overview of disparities in breast cancer (BC) care and biomarker testing, including barriers to testing, disparities in testing observed by subgroup and by test type, and approaches to reduce disparities in BC testing and care.
Download the Addressing Disparities in Care - Biomarker Testing in Breast Cancer Brochure (PDF 4.22 MB)

Early Breast Cancer Risk of Recurrence Profile

This resource is a brief handout providing an overview of early breast cancer (eBC) risk of recurrence, individualized risk assessment, and practical considerations for patient management to decrease risk in HR+/HER2- eBC. 
Download the Early Breast Cancer Risk of Recurrence Profile (PDF 0.25 MB)

Individualize the Risk of Recurrence in Early Breast Cancer

This resource provides an overview of the risk of recurrence in HR+ eBC, the importance of appropriate risk assessments in HR+/HER2- eBC, and considerations to further individualize risk assessment by combining complementary prognostic information.
Download the Individualize the Risk of Recurrence in Early Breast Cancer Brochure (PDF 3.6 MB)

Getting a Personalized Risk Assessment in Early Breast Cancer – A Patient Journey

This resource provides an overview of a hypothetical patient journey with early breast cancer (eBC), highlighting the important role the multidisciplinary team (MDT) plays when assessing risk, and clinical considerations for treatment decisions in HR+/HER2- eBC.
Download the Getting a Personalized Risk Assessment in Early Breast Cancer – A Patient Journey Case Study (PDF 1.0 MB)

Biomarker Testing in Metastatic Breast Cancer

This resource provides an overview of metastatic breast cancer (mBC), the role of the MDT in biomarker testing, and considerations for sample collection and biomarker testing in mBC.
Download the Biomarker Testing in Metastatic Breast Cancer Brochure (PDF 1.9 MB)

Biomarkers in Advanced and Metastatic Melanoma

This resource provides an overview of predictive and prognostic biomarkers in advanced or metastatic melanoma, as well as guideline recommendations for testing.
Download the Biomarkers in Advanced and Metastatic Melanoma Brochure (PDF 1.1 MB)

The Impact of Pan-Tumor Biomarker Testing

This resource provides an overview of pan-tumor biomarker testing and its importance in identifying therapy options for patients, including discussions of testing in select rare solid tumors, testing in neuro-oncology, and the utility of panel testing for pan-tumor biomarkers.
Download the Impact of Pan-Tumor Biomarker Testing Brochure (PDF 2.4 MB)

The Importance of a Molecular Diagnosis in Metastatic Non–Small Cell Lung Cancer (mNSCLC)

This resource provides an overview of biomarker testing in mNSCLC, the role of the MDT, testing with small samples, next-generation sequencing (NGS), and potential considerations to improve biomarker testing.
Download the Importance of a Molecular Diagnosis in mNSCLC Brochure (PDF 3.0 MB)

Hematology

These resources provide a detailed overview of biomarker testing approaches and challenges for hematologic disorders.

Recognizing PNH: The Importance of a Timely Diagnosis and Effective Management

This resource provides a quick overview of the common signs and symptoms of PNH, the importance of early intervention, and the role of biomarker testing for diagnosing and monitoring patients with PNH.

Download the Recognizing PNH: The Importance of a Timely Diagnosis and Effective Management 1-Pager (PDF 286 KB)

Biomarker Testing and Its Role in PNH 

This resource explores biomarker testing for patients with paroxysmal nocturnal hemoglobinuria (PNH). It provides relevant information on the role of biomarker testing with flow cytometry in diagnosing and monitoring PNH, the importance of routine monitoring, and additional PNH resources including a lab value tracker.

Download Biomarker Testing and Its Role in PNH (PDF 3.4 MB) 

Paroxysmal Nocturnal Hemoglobinuria Laboratory Contact Quick Reference List 

This resource provides a quick reference list for clinical laboratories offering flow cytometry testing along with a brief review of the importance of routing monitoring in PNH. 
Download the Paroxysmal Nocturnal Hemoglobinuria Laboratory Contact Quick Reference List (PDF 3.9 MB)

Paroxysmal Nocturnal Hemoglobinuria 1-Pager for Lab Values

This resource provides a quick reference for checking select lab values related to paroxysmal nocturnal hemoglobinuria (PNH) and a reminder of when to test patients using high-sensitivity flow cytometry.
Download the PNH Lab Values Flashcard (PDF 0.2 MB)

Identifying Paroxysmal Nocturnal Hemoglobinuria With Flow Cytometry

This resource enhances your understanding of PNH and its accurate diagnosis using flow cytometry.
Download the Identifying Paroxysmal Nocturnal Hemoglobinuria With Flow Cytometry Brochure (PDF 0.85 MB)

Understanding Challenges in Hematologic Diagnostics: Paroxysmal Nocturnal Hemoglobinuria

This resource provides a better understanding of the diagnostic challenges in patients with PNH.
Download the Understanding Challenges in Hematologic Diagnostics: Paroxysmal Nocturnal Hemoglobinuria Brochure (PDF 1.0 MB)

The Complement System for Paroxysmal Nocturnal Hemoglobinuria 

This resource provides a quick reference depicting the role of the complement system in PNH along with considerations for routine monitoring. 
Download the Complement System for Paroxysmal Nocturnal Hemoglobinuria 1-Pager (PDF 0.4 MB)